Forum Advisory Group member since 2016
Director Alliance Development, High Burden HIV Global Markets, Beckman Coulter Life Sciences
Tony works for Beckman Coulter Life Sciences, a Danaher company, within the Global Flow Cytometry Business Unit as Director Alliance Development. The purpose is to develop alliances and partnerships with global organizations committed to ending the HIV epidemic, including health policy, funders, implementing partners, NGOs and ministries of health. Tony has 30 years’ experience in the diagnostics and life science sector, mostly in commercial leadership roles. Previously, he was Commercial Director for Flow Cytometry in North America.
He sees his current work as a privilege and opportunity to interface with extremely talented individuals committed to supporting resource-limited settings. In the past seven years, Tony has learned about and travelled in resource-limited settings, primarily in Africa. This has inspired him to enhance his skills for increased effectiveness in public health matters.
Tony holds a Bachelor’s in management from Sigmund Weiss School of Business at Susquehanna University. He earned a post-graduate certificate in global health from Dornsife School of Public Health at Drexel University in 2017. He is completing his programme at the University of Liverpool to earn a Master’s in Public Health to improve his effectiveness for meaningful contributions to global health.
Tony is a Beckman Coulter’s dedicated resource for high burden HIV markets, primarily Africa, focused on HIV and AIDS, co-infection endemics and associated hematologic malignancies. Beckman Coulter is renewing its commitment to global health access to diagnostics through a strategy for participation centred on partnerships by launching the CARES Initiative, which Tony is leading. The initiative intends to identify ways to contribute to programmes that improve access to laboratory services and systems delivery through public-private partnerships. CARES is focused on supporting UNAIDS country targets, working through partnerships and alliances within the global community, identifying and addressing unmet needs related to endemics, and providing innovative solutions to addressing the most pressing needs in countries with the highest disease burden.